Advancements, challenges and future horizons in personalized psychiatry.
作者信息
Perna Giampaolo, Caldirola Daniela, Schatzberg Alan F, Nemeroff Charles B
机构信息
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Personalized Medicine Center for Anxiety and Panic Disorders, Humanitas San Pio X, Milan, Italy.
出版信息
World Psychiatry. 2024 Oct;23(3):460-461. doi: 10.1002/wps.21257.
Abstract
摘要
相似文献
1
Advancements, challenges and future horizons in personalized psychiatry.个性化精神病学的进展、挑战与未来展望。
World Psychiatry. 2024 Oct;23(3):460-461. doi: 10.1002/wps.21257.
2
Polypharmacy in Psychiatry: An In-depth Examination of Drug-drug Interactions and Treatment Challenges.精神科药物治疗：药物-药物相互作用与治疗挑战的深入探讨。
Curr Pharm Des. 2024;30(21):1641-1649. doi: 10.2174/0113816128297170240513105418.
3
Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders.个性化精神病学当前面临的挑战及未来可能的发展，重点关注精神障碍。
Heliyon. 2020 May 20;6(5):e03990. doi: 10.1016/j.heliyon.2020.e03990. eCollection 2020 May.
4
[Network analysis by systemic text excavation of the concept of personalized psychiatry and precision].[通过对个性化精神病学和精准概念的系统文本挖掘进行网络分析]
Encephale. 2021 Aug;47(4):341-347. doi: 10.1016/j.encep.2020.08.008. Epub 2020 Nov 12.
5
Sudan's mental health service: challenges and future horizons.苏丹的心理健康服务：挑战与未来展望。
BJPsych Int. 2020 Feb;17(1):17-19. doi: 10.1192/bji.2019.19.
6
Personalized medicine in psychiatry: ethical challenges and opportunities.精神病学中的个性化医疗：伦理挑战与机遇。
Dialogues Clin Neurosci. 2009;11(4):427-34. doi: 10.31887/DCNS.2009.11.4/kevers.
7
Deep learning opens new horizons in personalized medicine.深度学习为个性化医疗开辟了新视野。
Biomed Rep. 2019 Apr;10(4):215-217. doi: 10.3892/br.2019.1199. Epub 2019 Mar 13.
8
Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.药物基因组学在情绪障碍治疗中的应用：个性化精神病学的策略与机遇
EPMA J. 2017 Sep 5;8(3):211-227. doi: 10.1007/s13167-017-0112-8. eCollection 2017 Sep.
9
New horizons in psychiatry.精神病学的新视野
Wis Med J. 1955 Apr;54(4):221-8.
10
Precision and personalized assessment, diagnosis and treatment in psychiatry.精神病学中的精准和个性化评估、诊断和治疗。
CNS Spectr. 2021 Aug;26(4):326-332. doi: 10.1017/S1092852920000139. Epub 2020 Mar 31.
引用本文的文献
1
Was the COVID-19 Pandemic a Triggering Factor for PTSD in Adults? Results From A Systematic Review.新冠疫情是成年人创伤后应激障碍的触发因素吗？一项系统综述的结果
Actas Esp Psiquiatr. 2025 Aug;53(4):868-901. doi: 10.62641/aep.v53i4.1882.
2
Does Dysregulation Of The Indirect Pathway Contribute To The Pathophysiology Of Catatonia Through Neurotransmitter Imbalance?间接通路的失调是否通过神经递质失衡导致紧张症的病理生理学？
Clin Neuropsychiatry. 2025 Jun;22(3):229-242. doi: 10.36131/cnfioritieditore20250306.
3
Prescribing lithium for the management of persons suffering from bipolar disorders: expert consensus based on a Delphi study.开具锂盐用于双相情感障碍患者的治疗：基于德尔菲研究的专家共识
Int J Bipolar Disord. 2025 Jun 7;13(1):21. doi: 10.1186/s40345-025-00387-6.
4
Current limitations in technology-based cognitive assessment for severe mental illnesses: a focus on feasibility, reliability, and ecological validity.严重精神疾病基于技术的认知评估的当前局限性：关注可行性、可靠性和生态效度。
Front Behav Neurosci. 2025 Apr 7;19:1543005. doi: 10.3389/fnbeh.2025.1543005. eCollection 2025.
5
Anxiety disorders, PTSD and OCD: systematic review of approved psychiatric medications (2008-2024) and pipeline phase III medications.焦虑症、创伤后应激障碍和强迫症：已批准的精神科药物（2008 - 2024年）及III期在研药物的系统评价
Drugs Context. 2025 Apr 3;14. doi: 10.7573/dic.2024-11-2. eCollection 2025.
6
Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping.精神分裂症阴性症状评估：从共识会议衍生量表到远程数字表型分析
Brain Sci. 2025 Jan 17;15(1):83. doi: 10.3390/brainsci15010083.
7
Obsessive-Compulsive Symptoms in the General Population Under Stressful Conditions: Lessons Learned from the COVID-19 Pandemic.压力状态下普通人群的强迫症状：从新冠疫情中获得的经验教训
Brain Sci. 2024 Dec 19;14(12):1280. doi: 10.3390/brainsci14121280.
8
Effectiveness of a social cognition remediation intervention for patients with schizophrenia: a randomized-controlled study.一项针对精神分裂症患者的社会认知修复干预措施的有效性：一项随机对照研究。
Ann Gen Psychiatry. 2024 Dec 28;23(1):52. doi: 10.1186/s12991-024-00535-9.
本文引用的文献
1
Brain Circuit-Derived Biotypes for Treatment Selection in Mood Disorders: A Critical Review and Illustration of a Functional Neuroimaging Tool for Clinical Translation.脑回路衍生的生物型用于心境障碍的治疗选择：一种用于临床转化的功能神经影像学工具的批判性评价和说明。
Biol Psychiatry. 2024 Oct 1;96(7):552-563. doi: 10.1016/j.biopsych.2024.03.016. Epub 2024 Mar 27.
2
Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials.免疫代谢抑制特征作为抗抑郁治疗结局的预测因子：四项临床试验的汇总分析。
Br J Psychiatry. 2024 Mar;224(3):89-97. doi: 10.1192/bjp.2023.148.
3
Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions.难治性抑郁症：定义、患病率、检测、管理及研究性干预措施。
World Psychiatry. 2023 Oct;22(3):394-412. doi: 10.1002/wps.21120.
4
Clinical prediction models in psychiatry: a systematic review of two decades of progress and challenges.精神病学中的临床预测模型：二十年进展与挑战的系统回顾。
Mol Psychiatry. 2022 Jun;27(6):2700-2708. doi: 10.1038/s41380-022-01528-4. Epub 2022 Apr 1.
5
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials.基于德尔菲法的临床试验中治疗抵抗性抑郁症定义的共识指南。
Mol Psychiatry. 2022 Mar;27(3):1286-1299. doi: 10.1038/s41380-021-01381-x. Epub 2021 Dec 15.
6
Toward a personalized therapy for panic disorder: preliminary considerations from a work in progress.迈向惊恐障碍的个性化治疗：一项正在进行的工作的初步思考。
Neuropsychiatr Dis Treat. 2019 Jul 11;15:1957-1970. doi: 10.2147/NDT.S174433. eCollection 2019.
7
The revolution of personalized psychiatry: will technology make it happen sooner?个性化精神病学的革命：技术会让它更早实现吗？
Psychol Med. 2018 Apr;48(5):705-713. doi: 10.1017/S0033291717002859. Epub 2017 Oct 2.
Zotero 插件